Introduction {#Sec1}
============

Acute lower respiratory tract infections (ALRTIs) are a leading cause of morbidity and mortality worldwide, especially during the first years of life \[[@CR1]\]. They are responsible for 6.8% of deaths in neonates, 20% of deaths in children aged 1--12 mo and 12% of deaths in children aged 1 to 4 y \[[@CR2]\] and are considered to be responsible for 22% of deaths in children of age group 0--5 y in Southeast Asia \[[@CR3]\]. Respiratory infections are caused by a variety of viruses and bacteria with respiratory viruses being the commonest etiological agent of ALRTI among infants. There is a paucity of data regarding etiological agents for ALRTI among infants from western part of India \[[@CR4]\]. Data provided by studies carried out in different parts of India may have some lacunae, because of use of tests which are less sensitive or non-specific or are unable to detect wide range of pathogens simultaneously \[[@CR5]--[@CR9]\]. This data is of importance to ensure that unnecessary prescriptions of anti-bacterial agents are minimized, and appropriate measures are taken to limit the possibility of spread of nosocomial infections. The advent of diagnostic molecular methods (such as multiplex real-time polymerase chain reaction) provides a rare opportunity to identify viruses responsible for respiratory infections as these methods are more sensitive, more accurate and more efficient than traditional methods based on isolation, antibody-detection or serology and are capable of identifying multiple pathogens \[[@CR1]\].

Material and Methods {#Sec2}
====================

A prospective cross-sectional observational study was carried out in a tertiary care university-affiliated hospital in a metropolitan city in Western India after obtaining approval from the institutional ethics committee. Infants aged 1--12 mo of either gender with ALRTI were enrolled in the study after obtaining written informed consent from the parent or guardian. For the purpose of the study, ALRTI was defined as presence of cough with fever (temperature \> 38 °C) for \< 2 wk. with tachypnea (50 breaths or more breaths/ min), wheeze, stridor when calm, cyanosis, sub-costal retractions, or apnea \[[@CR5], [@CR10]\]. A detailed history was obtained from parent or guardian regarding various risk factors, which were defined in the manner given in Table [1](#Tab1){ref-type="table"} for the purpose of the study, differential diagnosis provided by the clinician were noted and the information was entered in the Case Record Form. The clinical diagnosis recorded was based on the clinician's perspective and judgement, which in turn, was made on the basis of information and data obtained from history, clinical examination findings and result of the laboratory and radiological investigation.Table 1Definition of terms used for describing the study populationRisk factorsDefinitionPremature babyBaby born before completion of 37 wk. of gestation, as determined by records or history.Low birth weightBirth weight less than 2.5 kg as determined by records or history.MalnourishmentActual weight less than -2SD on the Weight-for-age charts provided by WHO for the respective gender \[[@CR11]--[@CR13]\].Absence of exclusive breastfeedingAny food or drink other than breastmilk offered to the infant within first 6 mo of life.Exposure to smokeExposure to cigarette smoke, smoke from stove or chullahCongenital heart diseaseDetection of clinical features suggestive of a congenital heart disease confirmed by relevant investigations including ECG, radiography or two-dimensional echocardiography.

Nasopharyngeal secretions were collected using flocked swabs (Puritan Unitranz -- RT transport system containing swab and universal transport medium, Puritan Medical Products, USA) by following the standard procedure \[[@CR14]\]. Samples were immediately transported to the Molecular diagnostic laboratory, maintaining cold chain & were stored at −80 °C until further use.

Total nucleic acid was manually extracted using an RTP® Pathogen kit (Stratec molecular GmbH, Berlin, Germany) for simultaneous isolation of bacterial & viral DNA, plus viral RNA. Nucleic acid was extracted from 400 μL of universal transport medium containing nasopharyngeal swab (NPS) and was eluted to a final volume of 75 μL according to the RTP ® Pathogen protocol. An internal RNA virus control, the Brome Mosaic Virus (Fast-track Diagnostics, Luxembourg), was introduced into the lysis buffer with each sample, to monitor the nucleic acid extraction and reverse transcription.

Multiplex real time Reverse Transcriptase Polymerase Chain Reaction (RT-PCR):RT- PCR was performed using the FTD Respiratory Pathogen 21 plus (Fast-track Diagnostics, Luxembourg) for detection of Influenza A & B (Inf A & B); Inf A (H1N1) pdm 09; Respiratory syncytial virus (RSV A/B); Human rhinovirus (HRV); Human adenovirus (ADV); Human parainfluenza virus (PIV) 1,2,3,4; Human coronavirus (hCoV) OC43, HKU1, NL63, 229E; Human metapneumovirus (hMPV A/B); Human bocavirus (hBoV A/B); Enterovirus (EV); Parechovirus (PeV);*Chlamydia pneumoniae; Mycoplasma pneumoniae and Haemophilus influenzae* type b (Hib); as per the manufacturer's instruction. The reaction volume for each test was 25 μL, made up of 10 μL of nucleic acid and 15 μL of buffer/enzyme mix (Fast track mastermix). Amplification was performed in the ABI 7500 real-time PCR system thermocycler (Applied Biosystems, USA) using the following cycling conditions: 15 min at 42 °C, 3 min at 94 °C and 40 cycles of 8 s at 94 °C and 34 s at 60 °C. A fluorescence reading was taken at the 60 °C/34 s step in each cycle, and threshold cycle (Ct) values were determined by manual adjustment. Each sample was amplified in six parallel reactions, which contained primers and probes for four different targets, detecting viruses and bacteria, in addition to the internal control of the reaction. The positive and negative virus plasmid controls provided in the kit were included in all runs to monitor assay performance.

No follow-up or further contacts with the infants were kept post collection of nasopharyngeal swabs.

All data was entered in Microsoft excel sheet and frequencies of the etiological agent determined.

Results {#Sec3}
=======

One hundred infants (65 male infants, M:F = 1.86:1; Median age 6 mo; IQR: 5.5) with ALRTI admitted to the hospital during the study period (July 2014 through December 2015) were enrolled in the study. Fifty-two of them were diagnosed with bronchiolitis, while 48 were diagnosed with bronchopneumonia or pneumonia (radiographically, pulmonary infiltrates: 39, consolidation: 36 and hyperluscency: 25). As shown in Table [2](#Tab2){ref-type="table"}, all the enrolled children had cough, fever and breathlessness with varying durations.Table 2Duration of symptoms in the study populationSymptoms durationNo. of cases (*n* = 100)Cough Median duration (d): 3.00; IQR: 3\< 4 d564 to 7 d358 to 15 d9Cold (running nose/ rhinorrhea) Median duration (d): 3.00; IQR: 3\< 4 d584 to 7 d348 to 15 d8Fever (over 38 °C/ 100 °F) Median duration (d): 2.5; IQR: 2\< 4 d794 to 7 d178 to 15 d4Difficulty in breathing Median duration (d): 1.00; IQR: 1\< 4 d944 to 7 d68 to 15 d0

Eleven children had congenital heart disease, 10 were born prematurely while 27 had low birth-weight. Sixty-one infants were breastfed while 27 had history of exposure to smoke in their environment.

As shown in Table [3](#Tab3){ref-type="table"}, 82 samples were positive for at least one pathogen. Of the positive samples, the common pathogens detected were Respiratory syncytial virus \[RSV (29, 35.4%)\], HRV (21, 25.6%) and Adenoviruses \[ADV (18, 22%)\]. Influenza A other than H1N1, Influenza B, Human coronavirus (hCoV 229E) and Enterovirus (EV) were not detected.Table 3Pathogens identified by molecular testsPathogen identifiedCases with single detection (*n* = 54)Cases ofco-detection (*n* = 28)Total no. of cases (*n* = 82)Single: Co-detection ratio casesViruses identified Respiratory syncytial virus (RSV) A/B227293.14:1 Human rhinovirus (HRV)1110211.1:1 Adenovirus (ADV)99181:1 Human Bocavirus (hBoV)1781:7 Human metapneumovirus (hMPV) A/B3473:4 Influenza A (H1N1)3251.5:1 Parainfluenza virus (PIV) 32241:1 Parechovirus (PeV)0330 Parainfluenza virus (PIV) 20220 Parainfluenza virus (PIV) 40220 Human coronavirus (hCov) HKU10110 Human coronavirus (hCov) NL630110 Human coronavirus (hCov) OC43101NA Parainfluenza virus (PIV) 10110 Enterovirus (EV)000NA Human coronavirus (hCoV) 229E000NA Influenza A (non- H1N1)000NA Influenza B000NANon-virus organisms*Haemophilus influenzae b*0550*Chlamydia pneumoniae*202NA*Mycoplasma pneumoniae*0220

*M. pneumoniae, C. pneumoniae and H. influenzae type b* were the three bacteria detected.

As shown in Table [3](#Tab3){ref-type="table"}, 28 (34%) were positive for multiple pathogens, while 54 (66%) were positive for a single pathogen. Among the single detections, RSV was the most common virus detected, while HRV was the most common virus detected among the multiple detections. hCoV NL 63, hCoV HKU1, PIV 1, 2, 4, PeV, *M. pneumoniae* and *H. influenzae* type b were detected only in co- detections andnever as single pathogens, while *C. pneumoniae* was detected only as a single pathogen. No co-detections involved more than three pathogens. (Table [4](#Tab4){ref-type="table"}).Table 4Combination of identified combinations among co-detection of all respiratory pathogensPathogenHRVADVRSVhBoVHibhMPVPeVM.pnPIV2PIV3PIV4H1N1hCoV NL63hCoV HKU1PIV1HRV (*n*=10)NA111----1----2--1------ADV (*n* = 9)1NA131----------------1--RSV (*n* = 7)11NA11----2------------1hBoV (*n* = 7)131NA2--------------------Hib (*n* = 5)--112NA1------------------hMPV(*n* = 4)--1----1NA----1------------PeV (*n* = 3)----------1NA--------1------M.pn (*n* = 2)----2--------NA--------------PIV2 (*n* = 2)----------1----NA--1--1----PIV3 (*n* = 2)2----------------NA----------PIV4 (*n* = 2)------------1------NA--------H1N1 (*n* = 2)1----------1--------NA------hCoV NL63 (*n* = 1)----------------1------NA----hCoV HKU1 (*n* = 1)--1----------------------NA--PIV1 (*n* = 1)----1----------------------NAIncludes three patients with isolation of three organisms (HRV+ PIV4 + ADV, HRV + hMPV+ ADV and HRV + hMPV + PeV)*ADV* Adenoviruses; *hMPV* Human metapneumovirus; *HRV* Human rhinovirus; *PeV* Parechovirus; *PIV* Parainfluenza virus

Three infants (aged 4--6 mo) with LRTI (severe bronchopneumonia) succumbed after developing progressive worsening in clinical condition. Two of these infants had evidence of congenital heart disease. The infant without congenital heart disease, who succumbed to his illness had several risk factors such as premature birth, low birth weight, malnutrition and absence of exclusive breast feeding.

Discussion {#Sec4}
==========

The burden of viral LRTIs among infants in western India is poorly understood, due to paucity of published reports. This communication, which has used the latest technological advancement for identification of viral agents aims to fill this gap in the knowledge. The study has shown that up to 82% of samples of infants with symptoms of respiratory infection had positive viral agent identification. RSV, HRV, ADV, HBoV and HMPV were the predominant viruses identified.

RSV (A/B) was detected in 35.4% of study samples and this figure is well within the proportions (10--58%) reported in earlier studies \[[@CR6]--[@CR8], [@CR15], [@CR16]\]. This suggests that maternal antibodies are ineffective in preventing RSV infections during infancy, leading to substantial morbidity. HRV, the second most common virus that was detected was prevalent in 25.6% of infants, which is within the range of 0.5--33% \[[@CR1], [@CR7], [@CR15], [@CR17]\] as reported by other investigators. Earlier considered as the most common cause of upper respiratory tract infection (URTI), and less commonly less a cause of LRTI, HRV has further established its role also as a common cause of LRTIs among infants \[[@CR15]\]. ADV accounted for 22% of virus-detection-positive samples from infants. It has been described as one of the major causes of LRTI in children aged over 2 y and in adults, but not in infants \[[@CR18]\]. The present study findings seem to suggest that a rethink on these views could be in order. Human bocavirus was found in 9.8% of infants with positive samples. This virus has been frequently identified in infants, although its role in disease pathogenesis is not yet clear. Longtin et al. documented that prevalence rates are higher in children under 2 y of age, and that they decrease with age, which implies that the protection due to antibodies against hBoV is acquired during early life \[[@CR19]\]. The present study also detected the novel Influenza A (H1N1) pdm 09 virus in 6.1% (5/80) of the infants. Influenza A (other than the novel H1N1 pdm 09), was not detected, perhaps because the endemic Influenza A virus has been replaced or suppressed by the circulating novel H1N1 pdm 09 virus, as a result of the outbreak of H1N1virus that was reported starting early in 2015. The prevalence of *H. influenzae* type b (Hib) in developed countries has decreased, due to administration of Hib containing pentavalent vaccine; this pentavalent vaccine is included as part of the universal immunization program in several Indian states (Tamil Nadu, Kerala, Gujarat, Haryana, Karnataka, Goa, Jammu and Kashmir and Puducherry), but it was not implemented in Maharashtra during the period of this study, which explains detection of Hib in present study \[[@CR20]\].

Earlier studies have mentioned a co- infection rate of 2--82% \[[@CR1], [@CR6]--[@CR8], [@CR21]\]. In this study, multiple pathogens were noted in 34% (28/82) of the positive samples. HRV was the commonest virus to be detected in multiple detections. Co-infections have been increasingly reported in infants \[[@CR21]\]. The clinical significance of co-infections has not been fully elucidated. The authors cannot rule out the possibility that the high sensitivity of multiplex PCR may have led to the detection of residual nucleic acids from prior viral infections \[[@CR1]\]. For viruses like ADV and hBoV, lymphoid tissues are known to serve as reservoirs. This may lead to their prolonged shedding in an asymptomatic individual, and cause transmission of these viruses to other susceptible individuals \[[@CR22]\]. It is well-known that a few viruses like hCoV-NL63, HRV and hBoV continue to shed for a very long time after the onset of symptoms \[[@CR23]\]. In addition, the duration of shedding of viruses may depend on whether it was the sole pathogen or was accompanied by other co-pathogens \[[@CR24]\]. It is not surprising that HRV, ADV, hCoV NL63, hBoV were frequently detected in co-infections in present study. Because hBoV occurs so frequently with other viruses, it is still uncertain whether hBov is a pathogen, or just a concomitant bystander virus \[[@CR19]\]. Similarly, due to nasal carriage of pathogenic bacteria like *M. pneumoniae* and Hib, the results of nasopharyngeal swab may be misleading. However, HRV cannot be neglected as a persister, since it has been shown to be associated with worsening outcome, which could be attributed to its ability to reduce the capacity of bronchial epithelial cells to proliferate and self-repair \[[@CR25]\]. Thus, a positive result must be interpreted cautiously and correlated with the patient's clinical symptoms.

The difference in the positivity rates between the above-mentioned studies for detecting viruses/bacteria and the present study could be explained by various factors, like the different age groups of the patients, the difference in the types of samples collected, different diagnostic methods used, and also wide inter-regional variations with different climates. The issue of association between presence of risk factors or multiple pathogens and mortality could not be determined due to the small sample available. It could be the object of future research.

Use of a sensitive and novel method to detect viral agents is the strength of the study. The specimen of choice for the detection of respiratory viruses is a nasopharyngeal aspirate (NPA) or a nasal wash \[[@CR10], [@CR14]\]. But both have their own disadvantages such as unpleasantness of the procedure, need for a suction device in the case of NPA, and the attendant risk of aspiration and generation of aerosol during the collection of nasal wash. Hence, these procedures are not feasible for widespread use in clinical practice. In contrast, collecting a nasopharyngeal swab is easy, painless, can be performed anywhere and does not require any additional device. Also, the, newly developed flocked swabs (which were used in the study) are more sensitive, and less traumatic for pediatric patients, and are also more acceptable to the parents \[[@CR21]\]. The absence of a single test to detect all the etiological agents is the greatest hurdle in determining the etiological agent for cases with LRTI. Multiplex PCR has overcome this hurdle to some extent: it has the potential to both reduce the overall use of antibiotics and to improve the targeted use of antibiotics, which in turn can help control nosocomial transmission of viruses. However, the kit detects only the organisms mentioned above, and therefore may have missed other viruses and bacteria contributing to ALRTI. This may explain the 18 negative samples in the study. High concordance between the viruses identified using multiplex PCR on nasopharyngeal aspirates and those identified by studying pulmonary samples in patients with acute respiratory infections in previously published literature \[[@CR26], [@CR27]\] provides confidence that the organisms identified in this study in the nasopharyngeal aspirates were responsible for the lower respiratory infections. A case control study would be beneficial to know the presence of these viruses and bacteria in an asymptomatic infant. This could be an area of future research.

This study has established that it is feasible to use Multiplex PCR for detection of viral agents in the nasopharyngeal swabs. It has also provided a baseline data about the likely viruses that are detected in nasopharynx in infants with clinical manifestations of LRTI. Studies with larger sample with recruitment spanning all seasons can provide greater clarity about the contribution of various etiological agents.
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